DNTH
Dianthus Therapeutics, Inc. /DE/
NASDAQ · Healthcare · Biotechnology · US
$82.38
−0.39%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2880.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.93x
- Price / sales
- 2420.10x
- Price / cash flow
- -29.66x
Enterprise value
- Enterprise value
- $3.7B
- EV / sales
- 1955.01x
- EV / EBITDA
- -126.05x
- EV / EBIT
- -17.09x
- Market cap
- $4.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026